Elevance Health raises 2026 guidance for Elevance Health stock
Published on 10/25/2026 at 17:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGuidance and session dates
- On October 21, 2026, Elevance Health raised its full-year guidance.
- Elevance Health stock trades in weekend trading at Lang & Schwarz at EUR 393.10 at 5:33 p.m. CET on October 25, 2026.
- The next Xetra session is scheduled for October 26, 2026.
On October 21, 2026, Elevance Health reported third-quarter operating revenue of USD 50.40 billion and raised its full-year 2026 diluted earnings-per-share guidance to at least USD 22.00 and adjusted diluted earnings-per-share guidance to at least USD 29.00.
Elevance Health traded in weekend trading at Lang & Schwarz at EUR 393.10 at 5:33 p.m. CET on October 25, 2026. The Xetra closing reference for the last trading day was not available from the permitted dated Xetra sources.
The week in figures
The October 21 results release reported adjusted diluted earnings per share of USD 6.99 for the third quarter of 2026. Elevance Health also raised its full-year 2026 operating cash flow guidance to at least USD 6.50 billion.
The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Elevance Health stock.
Chronology of the week
On October 21, 2026, Elevance Health published its third-quarter results and guidance update. The company reported a benefit expense ratio of 90.6 percent for the quarter. The same day, it announced that Jeff Park would become President of Carelon effective December 1, 2026, according to the company release.
Dates of the coming week
The next Xetra session is scheduled for October 26, 2026. Elevance Health said its fourth-quarter 2026 dividend of USD 1.72 per share is payable on December 18, 2026, to shareholders of record at the close of business on December 4, 2026, as stated in its quarterly results release.
Market context: Market report S&P 500.
